» Authors » Nhu Hanh To

Nhu Hanh To

Explore the profile of Nhu Hanh To including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 98
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Belkacemi Y, Moran M, Ozden B, Masannat Y, Geara F, Albashir M, et al.
Crit Rev Oncol Hematol . 2024 Jun; 200:104421. PMID: 38876160
Breast reconstruction (BR) after mastectomy is important to consider for a woman's body image enhancement and psychological well-being. Although post-mastectomy radiation (PMRT) significantly improves the outcome of patients with high-risk...
2.
Thiolat A, Pilon C, Caudana P, Moatti A, To N, Sedlik C, et al.
Haematologica . 2023 Sep; 109(1):129-142. PMID: 37706355
Modulating an immune response in opposite directions represents the holy grail in allogeneic hematopoietic stem cell transplantation (allo-HSCT) to avoid insufficient reactivity of donor T cells and hematologic malignancy relapse...
3.
To N, Gabelle-Flandin I, Luong T, Loganadane G, Ouidir N, Boukhobza C, et al.
Cancers (Basel) . 2023 Apr; 15(7). PMID: 37046691
Background: Radiation therapy (RT), a novel approach to boost the anticancer immune response, has been progressively evaluated in the neoadjuvant setting in breast cancer (BC). Purpose: We aimed to evaluate...
4.
To N, Pilon C, Moatti A, Debesset A, Debbi K, Coraggio G, et al.
Strahlenther Onkol . 2023 Mar; 199(12):1242-1254. PMID: 36932237
Purpose: Effects of X‑ray energy levels used for myeloablative lethal total body irradiation (TBI) delivery prior to bone marrow transplantation (BMT) in preclinical mouse models were examined. Materials And Methods:...
5.
Belkacemi Y, Debbi K, Coraggio G, Bendavid J, Nourieh M, To N, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765902
Genomic classifiers such as the Genomic Prostate Score (GPS) could help to personalize treatment for men with intermediate-risk prostate cancer (I-PCa). In this study, we aimed to evaluate the ability...
6.
To N, Kossai M, Ouidir N, Grellier N, Assaf E, Gabelle-Flandin I, et al.
Rep Pract Oncol Radiother . 2023 Jan; 27(6):1114-1118. PMID: 36632297
No abstract available.
7.
To N, Radosevic-Robin N, Belkacemi Y
Rep Pract Oncol Radiother . 2022 Apr; 27(1):180-181. PMID: 35402032
No abstract available.
8.
To N, Nguyen H, Thiolat A, Liu B, Cohen J, Radosevic-Robin N, et al.
Breast Cancer Res Treat . 2022 Apr; 193(2):265-279. PMID: 35397079
Purpose: Radiation therapy (RT) for triple-negative breast cancer (TNBC) treatment is currently delivered in the adjuvant setting and is under investigation as a booster of neoadjuvant treatments. However, TNBC radioresistance...
9.
Moatti A, Debesset A, Pilon C, Beldi-Ferchiou A, Leclerc M, Redjoul R, et al.
J Immunother Cancer . 2022 Apr; 10(4). PMID: 35387779
Background: Targeting immune checkpoints that inhibit antitumor immune responses has emerged as a powerful new approach to treat cancer. We recently showed that blocking the tumor necrosis factor receptor-type 2...
10.
Debbi K, Loganadane G, To N, Kinj R, Husain Z, Chapet S, et al.
Br J Radiol . 2022 Feb; 95(1133):20210033. PMID: 35143326
Objectives: The aim of this retrospective study was to assess outcomes of SABR for metachronous isolated lung oligometastases from HNSCC. Methods: For patients who developed isolated, 1 or 2 lungs...